Table 1.
Clinical Characteristics and Body Composition in Oligo-amenorrheic Athletes (OA), Eumenorrheic Athletes (EA) and Non-athletes (NA)
OA (n=68) Mean±SD |
EA (n=24) Mean ± SD |
NA (n=26) Mean ± SD |
ANOVA p-value |
|
---|---|---|---|---|
Age (years) | 19.65 ± 2.58 | 18.21 ± 2.88 | 19.64 ± 2.18 | 0.04A |
Height (cm) | 165.1 ± 6.4 | 165.3 ± 7.7 | 161.7 ± 7.0 | 0.08 |
Weight (kg) | 57.1 ± 8.7 | 58.9 ± 7.3 | 57.2 ± 8.2 | 0.17 |
BMI (kg/m2) | 20.9 ± 2.4 | 22.2 ± 2.6 | 21.8 ± 2.5 | 0.04A |
REE (kcal/kg FFM) | 29.83 ± 5.58 | 30.79 ± 5.38 | 31.16 ± 4.76 | 0.51 |
Total Lean Mass (kg) | 42.4 ±5.5 | 45.6 ±7.4 | 39.5 ± 4.7 | 0.002A,C |
% Body Fat | 23.3 ±4.8 | 23.6±4.1 | 28.1 ± 6.2 | 0.002B,C |
Lumbar BMD Z-Scores | −0.66 ±1.21 | 0.03± 0.95 | −0.39 ± 1.03 | 0.04A |
Serum 25 (OH) vitamin D level (ng/ml) | 37.05±11.88 | 30.67±14.36 | 21.78±7.21 | <0.001A,C |
p<0.05 for OA vs. EA;
p<0.05 for OA vs. NA;
p<0.05 for OA vs. NA
OA: oligo-amenorrheic athletes; EA: eumenorrheic athletes; NA: non-athletes
Data presented as mean±SD. Significant p-values are bolded
ANOVA used for 3 groups comparisons followed by Tukey-Kramer test when ANOVA was significant